COM:GRAPHITEBIO
Graphite Bio, Inc.
- Stock
Last Close
3.27
21/03 20:00
Market Cap
185.19M
Beta: -
Volume Today
299.41K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|
average inventory | ||||||
average payables | 315K - | 1.54M 389.37% | 2.53M 64.16% | 1.43M 43.53% | ||
average receivables | ||||||
book value per share | -0.15 - | -1.91 1,161.80% | 13.28 794.11% | 5.40 59.34% | 0.00 99.94% | |
capex per share | -0.05 - | -0.20 339.19% | -0.12 39.46% | -0.00 99.84% | ||
capex to depreciation | -12.77 - | -7.82 38.75% | -2.80 64.15% | -2.75 1.97% | ||
capex to operating cash flow | 0.18 - | 0.11 38.70% | 0.07 30.99% | 0.12 60.93% | ||
capex to revenue | ||||||
cash per share | 0.00 - | 0.58 140,971.85% | 13.04 2,152.76% | 4.89 62.50% | 0.00 99.93% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 367.50 - | 0.03 - | 0.02 35.83% | 0.00 89.33% | ||
debt to equity | -0.99 - | 0.03 - | 0.02 33.40% | 0.00 89.92% | ||
dividend yield | ||||||
earnings yield | -0.00 - | -0.02 2,974.39% | -0.17 673.59% | -0.53 218.78% | -0.00 99.84% | |
enterprise value | 272.81M - | 612.67M 124.58% | -6.23M 101.02% | 140.24M 2,349.80% | 149.20B 106,282.58% | |
enterprise value over ebitda | -9.41K - | -8.98 99.90% | 0.09 100.98% | -1.33 1,606.98% | -1.10K 83,027.94% | |
ev to operating cash flow | -14.36K - | -70.25 99.51% | 0.12 100.17% | -1.59 1,451.51% | -1.66K 103,886.79% | |
ev to sales | ||||||
free cash flow per share | -0.00 - | -0.30 23,019.00% | -2.03 574.70% | -1.72 14.93% | -0.00 99.90% | |
free cash flow yield | -0.00 - | -0.02 23,019.00% | -0.16 904.17% | -0.52 218.49% | -0.00 99.87% | |
graham net net | -0.15 - | -1.99 1,215.47% | 12.42 722.43% | 4.42 64.39% | 0.00 99.93% | |
graham number | 0.21 - | 4.14 1,869.59% | 24.84 500.65% | 14.61 41.16% | 0.01 99.91% | |
income quality | 0.17 - | 0.13 26.83% | 0.75 485.59% | 0.87 16.56% | 0.72 17.06% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -0.36 - | -337.50 93,003.45% | -23.03 - | |||
interest debt per share | 0.16 - | 0.00 99.25% | 0.39 33,224.68% | 0.19 51.48% | 0.00 100.00% | |
inventory turnover | ||||||
invested capital | -0.99 - | 0.03 - | 0.02 33.40% | 0.00 89.92% | ||
market cap | 270.61M - | 632.46M 133.71% | 359.47M 43.16% | 182.18M 49.32% | 149.38B 81,895.40% | |
net current asset value | -2.22M - | -66.87M 2,914.83% | 363.80M 644.05% | 249.75M 31.35% | 183.15M 26.67% | |
net debt to ebitda | -75.83 - | 0.29 100.38% | 5.17 1,682.08% | 0.40 92.32% | 1.36 242.66% | |
net income per share | -0.01 - | -0.40 2,974.39% | -2.06 419.77% | -1.76 14.86% | -0.00 99.88% | |
operating cash flow per share | -0.00 - | -0.26 19,539.67% | -1.83 616.42% | -1.60 12.27% | -0.00 99.90% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -31.50 - | -0.60 98.09% | -0.15 75.32% | -0.30 101.75% | -0.66 120.72% | |
revenue per share | ||||||
roe | 0.09 - | 0.21 143.65% | -0.16 174.88% | -0.33 109.41% | -0.68 108.55% | |
roic | 3.87 - | 0.04 98.94% | -0.13 405.99% | -0.33 161.12% | -0.73 123.94% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | -0.15 - | -1.91 1,161.80% | 13.28 794.11% | 5.40 59.34% | 0.00 99.94% | |
stock based compensation to revenue | ||||||
tangible asset value | -2.22M - | -65.41M 2,848.96% | 384.05M 687.16% | 296.29M 22.85% | 183.58M 38.04% | |
tangible book value per share | -0.15 - | -1.91 1,161.80% | 13.28 794.11% | 5.40 59.34% | 0.00 99.94% | |
working capital | -2.22M - | -10.95M 393.46% | 369.59M 3,476.82% | 262.32M 29.02% | 183.22M 30.15% |
All numbers in (except ratios and percentages)